Think You Know the Latest in AAN MS Research?
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Dec 14, 2023
MEETING BRIEF
AAN 2023 Fall Conference: MS
The latest news from AAN 2023 Fall Conference on multiple sclerosis (MS), including featured articles and information about the conference.
Shared Decision-Making Tool May Improve Treatment Adherence for Patients With MS
Shared Decision-Making Tool May Improve Treatment Adherence for Patients With MS
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
PIRA Represents Most Common Form of Disability Accrual in Relapsing-Remitting MS
PIRA Represents Most Common Form of Disability Accrual in Relapsing-Remitting MS
Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.
Advertisement
PW QUIZ
Advertisement
Q&A: Examining Emerging Therapies to Restore Function in CNS Diseases in MS
Q&A: Examining Emerging Therapies to Restore Function in CNS Diseases in MS
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
In Primary Progressive MS, Age & Follow-Up Duration Predict Disease Activity
In Primary Progressive MS, Age & Follow-Up Duration Predict Disease Activity
For patients with primary progressive MS, age is a particularly important factor that predicts disease activity.
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
